
While the government is considering level 3 of social distancing, the pharmaceutical industry is also taking countermeasures.
Even if level 3 of social distancing are fully implemented, most of them maintain the flexible working system as they are now.
However, internal discussions on the scope of essential manpower are in full swing in that it is an administrative order to work from home except for the mandatory manpower.
◆Executive order to work from home except for required manpower when upgrading to level 3 According to the Central Disease Control Headquarters on the 14th, as of midnight on that day, the number of COVID-19 confirmed cases was 718.
It decreased by 312 from 1030 the previous day.
The number of COVID-19 confirmed cases in Korea exceeded 1,000 on the 13th as the third pandemic began in earnest.
The government expects the number of confirmed cases to increase to 1200 in the future.
The government recognizes the current situation as the biggest crisis since the outbreak of COVID-19.
As a final method, level 3 is also being considered.
Level 3 of social distancing is upgraded when the weekly average number of confirmed patients is 800-1000 or more.
President Moon Jae-in said at the Central Disaster and Safety Countermeasure Headquarters meeting urgently presided on the 13th, "If we can't break the spread now, we need to review level 3.
If Central Disease Control Headquarters believes it is inevitable, then boldly decide to (upgrade)." The pharmaceutical industry is also tense in that an executive order is issued to allow private companies to work from home if the social distancing level is elevated.
Looking at the government's step-by-step measures, in level 2.5, the recommendation to work from home for more than a third of the number of employees is reinforced to mandatory work from home outside of the required manpower.
However, it is up to the company to decide how to set up the required manpower.
With the recent surpassing 1,000, the possibility of level 3 is increasing (Source: Johns Hopkins) ◆Even now, only essential personnel are on the way to work The pharmaceutical industry is very nervous with government announcements.
The whole society is in 'shutdown' situation.
Officials on the front line are concentrating on preparing countermeasures while checking the government announcement in real time.
However, they are contemplating what specific measures to take.
Most pharmaceutical companies are already taking steps similar to level 3.
Even now, when level 2.5 is being applied, the rest of the workforce is working from home, except for the required manpower, so there is little to do when the social distancing into three stages is upgraded.
Accordingly, pharmaceutical companies are discussing the scope of mandatory manpower.
If the required manpower was previously team leader and a few team members, when the social distancing is upgraded, it is reduced to only team leader.
A representative of a domestic pharmaceutical company said, "The current company's official guidelines are Only essential personnel go to work, but in fact, the team is divided into two groups or three groups to go to work every other day.
If it is upgraded to level 3, only the team leader goes to work.
He expects the rest to go to work only in very urgent cases under the judgment of the team leader.
Another domestic pharmaceutical company official said, "Before the implementation of level 2.5, we have been selectively working from home.
Even if it is reinforced to level 3, it is not expected that the company will decide whether to go to work or stay at home according to the position or job group.
Under the conditions, it is decided whether to work from home, but each team leader will select the required manpower based on a tighter standard." “We are preparing separate guidelines at the company.
The overall direction is the same.
We freely decide to go to work and home in consideration of personal circumstances and work environment.
However, in case of upgrading to level 3, working from home is given priority.”

another official from a domestic pharmaceutical company, said, "If the company is upgraded to level 3, all sales workers will be converted to telecommuting.
Researchers will also participate in telecommuting, leaving only a small number of personnel." “In the case of production workers, it takes a month or two to restart even if the factory stops operating for one day.
In the case of production workers, it will inevitably continue to work.
However, measures such as changing from the current three shifts to two shifts are under discussion." Some say that even if it is upgraded to level 3, it will remain the same as the present.
Mr.
E, an official at a domestic pharmaceutical company, said, “It is already common to work from home.
All sales workers are at home, and all employees in the rest of the field come to work.
It is difficult to further reduce the required manpower.” Another domestic company official, Mr.
F, said, "Officially, under the judgment of the manager, only essential personnel are instructed to go to work.
However, almost all of the employees are present.
Therefore, even if the level is raised to 3, the manager judges everyone as essential personnel.
If so, nothing will change from now.”
댓글 운영방식은
댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.
댓글 노출방식은
댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.
댓글의 삭제 기준은
다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.
저작권·인격권 등 타인의 권리를 침해하는 경우
상용 프로그램의 등록과 게재, 배포를 안내하는 게시물
타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물
근거 없는 비방·명예를 훼손하는 게시물
특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우
특정 지역 및 종교간의 감정대립을 조장하는 내용
사실 확인이 안된 소문을 유포 시키는 경우
욕설과 비어, 속어를 담은 내용
정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)
특정 지역이나 단체를 비하하는 경우
특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우
특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우
타인의 ID 혹은 닉네임을 도용하는 경우
게시판 특성상 제한되는 내용
서비스 주제와 맞지 않는 내용의 글을 게재한 경우
동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우
부분적으로 변경하여 반복 게재하는 경우도 포함
제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우
돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물
게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우
수사기관 등의 공식적인 요청이 있는 경우
기타사항
각 서비스의 필요성에 따라 미리 공지한 경우
기타 법률에 저촉되는 정보 게재를 목적으로 할 경우
기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용
사실 관계 확인 후 삭제
저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우
타인의 초상권을 침해하거나 개인정보를 유출하는 경우
당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)
※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.
※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.
※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.